302440 — SK Bioscience Co Share Price
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩268bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.76 | ||
| Price to Tang. Book | 1.89 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 11.83 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -4.86% | ||
| Return on Equity | -2.86% | ||
| Operating Margin | -45.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 225,610.78 | 929,000.93 | 456,725.87 | 369,505.56 | 267,545.05 | 630,522 | 708,480 | 7.78% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +118.15 | +807.61 | -66.84 | -81.18 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SK Bioscience Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of biological products. The Company's main products include vaccines such as SKYCellflu and Rotatech. The Company also sells infusion solutions. In addition, the Company engages in technology export business. The Company sells its products in domestic and overseas markets.
Directors
- Jae Yong Ahn CEO (54)
- Hun Kim CTO (54)
- Mi Jin Cho NID (59)
- Jeong Wuk Choi NID (57)
- Yik Hwan Gwon NID (54)
- Chang Jin Moon NID (68)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 1st, 2018
- Public Since
- March 18th, 2021
- No. of Shareholders
- 269,991
- No. of Employees
- 1,067
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KSE
- Shares in Issue
- 78,369,145
- Address
- 310, Pangyo-ro, Bundang-gu, SEONGNAM, 13494
- Web
- https://www.skbioscience.co.kr/
- Phone
- +82 220082200
- Auditors
- Ernst & Young Han Young
Upcoming Events for 302440
Q1 2025 SK Bioscience Co Ltd Earnings Release
Q2 2025 SK Bioscience Co Ltd Earnings Release
Similar to 302440
Aprogen Biologics
Korea Exchange - KSE
Boryung
Korea Exchange - KSE
Bukwang Pharm Co
Korea Exchange - KSE
Chong Kun Dang Pharmaceutical
Korea Exchange - KSE
CKD Bio
Korea Exchange - KSE
FAQ
What is the SK Bioscience Co share price?
As of Today at 23:17 UTC, shares in SK Bioscience Co are trading at KR₩40,400. This share price information is delayed by 15 minutes.
How has the SK Bioscience Co share price performed this year?
Shares in SK Bioscience Co last closed at KR₩40,400 and the price had moved by -29.65% over the past 365 days. In terms of relative price strength the SK Bioscience Co share price has underperformed the FTSE Developed Asia Pacific Index by -28.85% over the past year.
What are the analyst and broker recommendations for SK Bioscience Co?
The overall consensus recommendation for SK Bioscience Co is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the SK Bioscience Co dividend yield?
SK Bioscience Co does not currently pay a dividend.
Does SK Bioscience Co pay a dividend?
SK Bioscience Co does not currently pay a dividend.
When does SK Bioscience Co next pay dividends?
SK Bioscience Co does not currently pay a dividend.
How do I buy SK Bioscience Co shares?
To buy shares in SK Bioscience Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of SK Bioscience Co?
As of the previous close price of KR₩40,400, shares in SK Bioscience Co had a market capitalisation of KR₩3tn.
Where are SK Bioscience Co shares listed?
Here are the trading details for SK Bioscience Co:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 302440
What kind of share is SK Bioscience Co?
Based on an overall assessment of its quality, value and momentum SK Bioscience Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a SK Bioscience Co share price forecast for 2025?
The analyst consensus target price for shares in SK Bioscience Co is KR₩47,866. That is 18.48% above the last closing price of KR₩40,400.
Analysts covering SK Bioscience Co currently have a consensus Earnings Per Share (EPS) forecast of -KR₩981 for the next financial year.
Find out moreWhat is the trend in the SK Bioscience Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SK Bioscience Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -18.05%.
As of the last closing price of KR₩40,400, shares in SK Bioscience Co were trading -19.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the SK Bioscience Co PE Ratio?
The SK Bioscience Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩40,400.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of SK Bioscience Co?
SK Bioscience Co's management team is headed by:
- Jae Yong Ahn - CEO
- Hun Kim - CTO
- Mi Jin Cho - NID
- Jeong Wuk Choi - NID
- Yik Hwan Gwon - NID
- Chang Jin Moon - NID